entertainment -WSS

entertainment

author：knowledge 2025-09-27 23:01:11 - browse：85

Mouse embryo in bottle. -- coverage from STAT — A mouse embryo model created entirely from stem cells. Scientists have since used similar systems to build models of human embryos. Jacob Hanna —Weizmann Institute

Earlier this month, a British journalist broke the news that researchers had taken a major step toward growing stem cells into structures that resemble human embryos.

Details about the experiments, and any sort of outside analysis of their quality or significance, were scarce, since the academic paper summarizing the work was still under peer review. But as the news spread around the globe, other scientists who had more quietly been working in the same area quickly posted preprints of their own progress.

Almost overnight, it seemed, the world was awash in different ways to coax stem cells into something that looked like the earliest days of a human life. The pushback was immediate, prompting accusations of overblown claims as well as outcry about ethical considerations and legal guardrails lagging behind the pace of scientific progress. Meanwhile, former Trump adviser Steve Bannon’s podcast, which studies have found to be a top spreader of misinformation, denounced synthetic babies as “the next abomination.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Readout Newsletter: Bristol, Sangamo, Gilead, and more

hotspot

WSS

How generative AI is inspiring dreams of a health data revolution

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Medicare coverage of Wegovy, once blocked, now looks possible

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Weighted lottery helped low

hotspot

entertainment

focus

How to save PrEP access — and even expand it

Weighted lottery helped low

BioMarin wins approval for gene therapy to treat hemophilia A

Listen: Biogen's potential pivot, & Illumina's next chapter

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Listen: Biogen's potential pivot, & Illumina's next chapter

ChatGPT in medicine: STAT answers readers' burning questions

Male and female sex labels in research insufficient, scientists say

After affirmative action ruling, medical educators look to 'holistic review'

Why depression after traumatic brain injury is distinct

knowledge

John Green on his newest strategy for fighting tuberculosis

UCLA team creates talking throat patch for voice disorders

'Make People Better': The CRISPR babies story you probably don't know

Change Healthcare outage fallout shows need for new oversight

ALS advocates say criticism of new drugs misses bigger picture

ALS advocates say criticism of new drugs misses bigger picture

hotspot

hotspot

focus

focus